The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.

RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2.  The participants in this study are people who get tested for COVID-19 in a GGD test lane.

In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.

The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.

The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.

It is estimated that about one-third of nursing homes in the Netherlands have at least one patient with COVID-19.

The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers published by RIVM.

There are significant regional differences in the coronavirus epidemic in the Netherlands.